DILI imaging of hepatocytes

DILI imaging of hepatocytes cultured on Cell-able® with CellVoyager CQ1

CellVoyager CQ1 and Cell-able® plates are applicable to drug-induced liver injury (DILI) study utilizing high content screening assay as shown in the following.

DILI imaging of hepatocytes

Experimental:

Human primary hepatocytes were co-cultured on Cell-able® with 3T3-Swiss albino mouse fibroblast cells. The 3D spheroids were stained with monochlorobimane (mBCl) for reduced glutathione (GSH/ blue), Bodipy 493/503 for lipid droplets (Oil/green), Tetramethylrhodamine methyl ester (TMRM) for mitochondrial membrane potential (MMP/ red) and HCS Nuclera Mask Deep Red for nuclei (purple) after 3-days exposure with Aspirin (negative compound) and Troglitazone (positive compound). The images were acquired with with CellVoyager CQ1.

Cell-able is a registered trademark of Toyo Gosei Co., Ltd. in US and Japan.

Link to Toyo Gosei Co., Ltd. :


Our Social Medias

We post our information to the following SNSs. Please follow us.

  Follow us Share our application
•Twitter @Yokogawa_LS Share on Twitter
•Facebook Yokogawa Life Science Share on Facebook
•LinkedIn Yokogawa Life Science Share on LinkedIn

 

Yokogawa's Official Social Media Account List

Social Media Account List


Related Products & Solutions

  • CellPathfinder

    CellPathfinder is designed for our HCA systems, CQ1 and the CellVoyager series. From beginners to experts, the analysis software lets you quantify subtle physiological changes and even label-free samples with various graph options.

    See More
  • CV8000 High-Throughput System

    CellVoyager CV8000 is the most advanced high-content screening system. The improved built-in incubator lets you analyze extended live cell responses. With its expandability, 4 cameras, 5 lasers and an optional built-in pipettor, the system permits increasingly complex assay development and high-content screening.

    See More

Top